Publication Name	World Journal of Biological Chemistry
Manuscript ID	30366
Country	Sri Lanka

Received	2016-09-29 09:03
Peer-Review Started	2016-10-07 20:51
To Make the First Decision	2016-11-10 08:57
Return for Revision	2016-11-14 13:49
Revised	2016-11-22 03:18
Second Decision	2017-01-04 15:42
Accepted by Journal Editor-in-Chief	2017-01-04 15:50
Accepted by Company Editor-in-Chief	2017-01-14 15:23
Articles in Press	2017-01-14 15:24
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-02-20 08:58
Publish the Manuscript Online	2017-02-25 15:11

ISSN	1949-8454 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Biochemistry & Molecular Biology
Manuscript Type	Minireviews
Article Title	Use of thyroglobulin as a tumour marker
Manuscript Source	Invited Manuscript
All Author List	Buddhike Sri Harsha Indrasena
Funding Agency and Grant Number
Corresponding Author	Buddhike Sri Harsha Indrasena, MBBS (Hons), MS (Surgery), MSc (Statistics), MRCS(Ed), Consultant General and Endocrine Surgeon, Kandy General Hospital (Teaching), William Gopallawa Mawatha, Kandy 20000, Sri Lanka. indrasenaharsha@gmail.com
Key Words	Thyroglobulin; Thyroid cancer; Recurrent thyroid cancer; Anti-thyroglobulin antibodies; Tumour marker
Core Tip	Although serum thyroglobulin (TG) is widely used as a tool to detect recurrence of thyroid cancer, it is widely held that preoperative TG measurement is unnecessary. It is true that preoperative TG level is hardly of much diagnostic value, but without a preoperative TG report, it is not possible to safely utilize serial serum TG subsequently as a monitoring tool. Routine measurement of serum TG before surgery is, therefore, recommended.
Publish Date	2017-02-25 15:11
Citation	Indrasena BSH. Use of thyroglobulin as a tumour marker. World J Biol Chem 2017; 8(1): 81-85
URL	http://www.wjgnet.com/1949-8454/full/v8/i1/81.htm
DOI	http://dx.doi.org/10.4331/wjbc.v8.i1.81

Full Article (PDF)	WJBC-8-81.pdf
Full Article (Word)	WJBC-8-81.doc
Manuscript File	30366-Review.doc
Answering Reviewers	30366-Answering reviewers.pdf
Audio Core Tip	30366-Audio core tip.wma
Conflict-of-Interest Disclosure Form	30366-Conflict-of-interest statement.pdf
Copyright License Agreement	30366-Copyright assignment.pdf
Peer-review Report	30366-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	30366-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	30366-Scientific misconduct check.pdf
Scientific Editor Work List	30366-Scientific editor work list.pdf